IDENTIFYING THERAPEUTIC VULNERABILITIES IN NRF2 DEPENDENT CANCERS

被引：0
|
作者：
Levonen, Anna-Liisa [1 ]
机构：
[1] Univ Eastern Finland, Kuopio, Finland
来源：
FREE RADICAL BIOLOGY AND MEDICINE | 2022年 / 189卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [41] NRF2 as a therapeutic opportunity to impact in the molecular roadmap of ALS
    Jimenez-Villegas, J.
    Ferraiuolo, L.
    Mead, R. J.
    Shaw, P. J.
    Cuadrado, A.
    Rojo, A. I.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 173 : 125 - 141
  • [42] Potential therapeutic effects of Nrf2 activators on intracranial hemorrhage
    Imai, Takahiko
    Matsubara, Hirofumi
    Hara, Hideaki
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2021, 41 (07): : 1483 - 1500
  • [43] Phytochemical activators of Nrf2: a review of therapeutic strategies in diabetes
    Qin, Si
    Chen, Zhong
    Wen, Yiling
    Yi, Yuhang
    Lv, Chenghao
    Zeng, Chaoxi
    Chen, Lanming
    Shi, Meng
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (01): : 11 - 22
  • [44] Nrf2 is a potential therapeutic target in radioresistance in human cancer
    Zhou, Suna
    Ye, Wenguang
    Shao, Qiuju
    Zhang, Mingxin
    Liang, Jun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (03) : 706 - 715
  • [45] The therapeutic effect of NRF2 activator, ezetimibe, in cardiac cachexia
    Vashi, Ruju
    Joshi, Mit
    Patel, Bhoomika M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 (06) : 1131 - 1142
  • [46] Activation of the Nrf2 Pathway as a Therapeutic Strategy for ALS Treatment
    Arslanbaeva, Liaisan
    Bisaglia, Marco
    MOLECULES, 2022, 27 (05):
  • [47] Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma
    Cucci, Marie Angele
    Grattarola, Margherita
    Monge, Chiara
    Roetto, Antonella
    Barrera, Giuseppina
    Caputo, Emilia
    Dianzani, Chiara
    Pizzimenti, Stefania
    ANTIOXIDANTS, 2023, 12 (06)
  • [48] Nrf2 as a Potential Therapeutic Target for Traumatic Brain Injury
    Abdul-Muneer, P. M.
    JOURNAL OF INTEGRATIVE NEUROSCIENCE, 2023, 22 (04)
  • [49] Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
    Vargas-Mendoza, Nancy
    Morales-Gonzalez, Angel
    Morales-Martinez, Mauricio
    Soriano-Ursua, Marvin A.
    Delgado-Olivares, Luis
    Sandoval-Gallegos, Eli Mireya
    Madrigal-Bujaidar, Eduardo
    alvarez-Gonzalez, Isela
    Madrigal-Santillan, Eduardo
    Morales-Gonzalez, Jose A.
    BIOMEDICINES, 2020, 8 (05)
  • [50] Nrf2/ARE Pathway as a Therapeutic Target for the Treatment of Parkinson Diseases
    Gureev, Artem P.
    Popov, Vasily N.
    NEUROCHEMICAL RESEARCH, 2019, 44 (10) : 2273 - 2279
12345